Your browser doesn't support javascript.
loading
Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.
Ahluwalia, Manmeet S; Bou-Anak, Stephanie; Burgett, Monica E; Sarmey, Nehaw; Khosla, Divya; Dahiya, Saurabh; Weil, Robert J; Bae, Eunnyung; Huang, Ping; McGraw, Mary; Grove, Lisa M; Olman, Mitchell A; Prayson, Richard A; Suh, John H; Gillespie, G Yancey; Barnholtz-Sloan, Jill; Nowacki, Amy S; Barnett, Gene H; Gladson, Candece L.
Afiliación
  • Ahluwalia MS; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH, USA.
  • Bou-Anak S; Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
  • Burgett ME; Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
  • Sarmey N; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH, USA.
  • Khosla D; Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
  • Dahiya S; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH, USA.
  • Weil RJ; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH, USA.
  • Bae E; Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
  • Huang P; Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
  • McGraw M; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH, USA.
  • Grove LM; Department of Pathobiology, Lerner Research Institute, The Cleveland Clinic, Cleveland, OH, USA.
  • Olman MA; Department of Pathobiology, Lerner Research Institute, The Cleveland Clinic, Cleveland, OH, USA.
  • Prayson RA; Anatomic Pathology Laboratory, The Cleveland Clinic, Cleveland, OH, USA.
  • Suh JH; Radiation Oncology, The Cleveland Clinic, Cleveland, OH, USA.
  • Gillespie GY; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Barnholtz-Sloan J; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Nowacki AS; Quantitative Health Sciences, The Cleveland Clinic, Cleveland, OH, USA.
  • Barnett GH; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH, USA.
  • Gladson CL; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH, USA. gladsoc@ccf.org.
J Neurooncol ; 131(3): 449-458, 2017 02.
Article en En | MEDLINE | ID: mdl-27858267

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Receptores Tipo I de Factores de Necrosis Tumoral / Receptores Tipo II del Factor de Necrosis Tumoral / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Receptores Tipo I de Factores de Necrosis Tumoral / Receptores Tipo II del Factor de Necrosis Tumoral / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos